Artemis Medicare Services Ltd

CARE Ratings Ltd.’s recent monitoring agency report reveals that Artemis Hospitals has utilized Rs 136.89 crore of the Rs 330 crore raised through a recent issuance as of the end of Q1FY27, leaving Rs 193.11 crore unutilized and primarily held in fixed deposits with HDFC, ICICI, and Axis banks. The report, covering the period ending Q1FY27, indicates Rs 17.45 crore was deployed for acquisitions, expansion, and capital expenditures, including medical equipment for a hospital in Raipur and construction in Delhi. The original timeline for fund utilization, initially set for May 15, 2026, has been extended to November 15, 2027, and no funds were used for general corporate purposes during the quarter. The report notes that the accuracy of the findings relies on information provided by Artemis Hospitals.

Artemis Medicare Services Ltd share price slipped 1.75% to Rs 297.45. The Company's net profit inched up 3.83% to Rs 31.44 crore, while revenue from operations slightly gained 2.90% to Rs 287.32 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 4.99 lakh crore, rising 3.87%. It has improved by 0.45% over last one week and spiked sharply by 17.80% in last one month while the market capitalization of Artemis Medicare Services Ltd has marginally improved by 6.82% and 18.11% in the same period respectively. Profit before tax (PBT) of Artemis Medicare Services Ltd stood at Rs 42.63 crore in Q2 FY26, expanding by 43.15% year-on-year, and easing 5.91% quarter-on-quarter. EBITDA came in at Rs 51 crore, rallying 48.19% YoY and surging by 16.59% sequentially. Total expenses saw a slight increase of 1.34% to Rs 243.61 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 42.84 crore, registering a marginal contraction of 4.74% YoY. For the TTM ended FY26, revenue from operations grew 15.40% to Rs 1081.24 crore, while net profit soared by 26.21% to Rs 103.72 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 12070% to Rs 158.35 crore, and PBT surged 29.27% to Rs 139.18 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 131.95 crore in FY26, as against Rs 145.62 crore in FY25. Artemis Medicare Services Ltd rallied 24.53% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 3.81% during the same period.

Artemis Medicare Services Ltd reported consolidated revenue from operations of Rs 28,732 crore for the quarter ended June 30, 2026, a 12.7% increase year-over-year, according to a press release. The company’s EBITDA rose 27.9% to Rs 6,182 crore, and profit increased 48.3% to Rs 3,144 crore. Artemis Hospital Gurgaon’s revenue from operations increased 15.4% to Rs 27,849 crore, with a bed capacity utilization of 65.7% and average revenue per occupied bed of Rs 85,690. The company commenced operations at its Raipur hospital in July 2026, marking an expansion into new markets.

Artemis Medicare Services Limited informed the National Stock Exchange of India Limited and BSE Limited that Sanjib Sen (DIN: 07088442) has ceased to be a Director of the company upon completion of his tenure as an Independent Director on August 2, 2026.

Artemis Medicare Services Limited announced that its shareholders approved the re-appointment of M/s. T R Chadha & Co LLP, Chartered Accountants, as Statutory Auditors for a second term of 5 years, from the conclusion of the 22nd Annual General Meeting held on July 31, 2026, until the conclusion of the 27th AGM in 2031.

Artemis Medicare Services Limited announced that its shareholders approved the appointment of Dr. Girdhar Jessaram Gyani (DIN: 05169157) as an Independent Director for a term of 3 years, effective August 1, 2026, at the company’s 22nd Annual General Meeting held on July 31, 2026.

Artemis Medicare Services Limited will hold a board meeting on August 3, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, as announced in a communication dated June 29, 2026; the trading window for the company's securities was closed from July 1, 2026, and will remain closed until August 5, 2026.

Artemis Medicare Services has fixed 10 July 2026 as record date for purpose of final dividend.

The board of Artemis Medicare Services has approved the appointment of Tapan Mitra (DIN: 08445248) as an Additional Director in the capacity of Independent Director for a period of 3 years, effective from 08 May 2026.

Artemis Medicare Services announced that the Board of Directors of the Company at its meeting held on 8 May 2026, inter alia, have recommended the final dividend of Rs 0.45 per equity Share (i.e. 45%) , subject to the approval of the shareholders.